View in EDS

The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis.

Saved in:

Bibliographic Details
Title:	The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis.
Authors:	Zhang, Yingshi^1,2 (AUTHOR) zhangyingshi@syphu.edu.cn, Xu, Xiangbo^1,2 (AUTHOR) xxb_1104@sina.cn, Yang, Kaisi^1,2 (AUTHOR) syphuyks100@163.com, Wang, Shuai^1,2 (AUTHOR) ws322577@163.com, Zhang, Tianqi^1,2 (AUTHOR) 18940967573@163.com, Hui, Fuhai² (AUTHOR) huifuhai@163.com, Zheng, Fangyuan^1,2 (AUTHOR) zhengfangyuanzxq@163.com, Geng, Hefeng^1,2 (AUTHOR) x876892517@163.com, Xu, Chang^1,2 (AUTHOR) Charlottexu1996@163.com, Xun, Fanghua^1,3 (AUTHOR) 15690510226@163.com, Xu, Ziang^1,2 (AUTHOR) Xza13842350393@163.com, Wang, Chengkang^1,2 (AUTHOR) W1877816073@outlook.com, Hou, Shanbo⁴ (AUTHOR) shanbohou@luoxin.cn, Song, Aigang⁴ (AUTHOR) aigangsong@luoxin.cn, Ren, Tianshu^1,2 (AUTHOR) sz_pharm@163.com, Zhao, Qingchun^1,2 (AUTHOR) zhaoqingchun1967@163.com
Source:	European Journal of Pharmacology. Nov2024, Vol. 983, pN.PAG-N.PAG. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	00142999
DOI:	10.1016/j.ejphar.2024.176952